McKesson Cash Flow from Investing Activities 2010-2023 | MCK
McKesson annual/quarterly cash flow from investing activities history and growth rate from 2010 to 2023. Cash flow from investing activities can be defined as the total change in cash resulting from a companies investments
- McKesson cash flow from investing activities for the quarter ending December 31, 2023 was $-0.495B, a 66.11% increase year-over-year.
- McKesson cash flow from investing activities for the twelve months ending December 31, 2023 was $-1.501B, a 546.98% increase year-over-year.
- McKesson annual cash flow from investing activities for 2023 was $-0.542B, a 508.99% increase from 2022.
- McKesson annual cash flow from investing activities for 2022 was $-0.089B, a 78.55% decline from 2021.
- McKesson annual cash flow from investing activities for 2021 was $-0.415B, a 28.32% decline from 2020.
McKesson Annual Cash Flow Investing
(Millions of US $) |
| 2023 |
$-542 |
| 2022 |
$-89 |
| 2021 |
$-415 |
| 2020 |
$-579 |
| 2019 |
$-1,381 |
| 2018 |
$-2,993 |
| 2017 |
$-3,269 |
| 2016 |
$-1,557 |
| 2015 |
$-677 |
| 2014 |
$-5,046 |
| 2013 |
$-2,209 |
| 2012 |
$-1,502 |
| 2011 |
$-624 |
| 2010 |
$-309 |
| 2009 |
$-727 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical & Dental Supplies |
$71.697B |
$308.951B |
|
McKesson Corporation is a health care services and information technology company. McKesson operates through two segments: The Distribution Solutions segment distributes branded and generic pharmaceutical drugs along with other healthcare-related products on a global basis worldwide. The segment also provides practice management, technology, clinical support and business solutions to community-based oncology and other specialty practices. In addition, the segment provides specialty pharmaceutical solutions for pharmaceutical manufacturers including offering multiple distribution channels and study access to oncology physicians. The Technology Solutions segment provides enterprise-wide clinical, patient care, financial, supply chain, and strategic management software solutions. per segment realignment, McKesson reported revenues through four segments: U.S. Pharmaceutical and Specialty Solutions, Internation, Medical-Surgical Solutions and Prescription Technology Solutions.
|
